Does ALIROCUMAB Cause Product dose omission? 1,354 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 1,354 reports of Product dose omission have been filed in association with ALIROCUMAB (Praluent). This represents 5.9% of all adverse event reports for ALIROCUMAB.
1,354
Reports of Product dose omission with ALIROCUMAB
5.9%
of all ALIROCUMAB reports
1
Deaths
63
Hospitalizations
How Dangerous Is Product dose omission From ALIROCUMAB?
Of the 1,354 reports, 1 (0.1%) resulted in death, 63 (4.7%) required hospitalization.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 1,354 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
Device issue (785)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
DIMETHYL (1,248)
TOFACITINIB (1,104)
Which ALIROCUMAB Alternatives Have Lower Product dose omission Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN